Gene from a psoriasis susceptibility locus primes the skin for inflammation

Science Translational Medicine

Volumn 2, Issue 61, 2010, Pages

  Wolf, Ronald ^a,b   Mascia, Francesca ^a   Dharamsi, Alif ^a   Howard, O M Zack ^c   Cataisson, Christophe ^a   Bliskovski, Val ^a   Winston, Jason ^a   Feigenbaum, Lionel ^d   Lichti, Ulrike ^a   Ruzicka, Thomas ^b   Chavakis, Triantafyllos ^a,e   Yuspa, Stuart H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c NATIONAL CANCER INSTITUTE   (United States)

^d SAIC FREDERICK INC   (United States)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; DOXYCYCLINE; ETANERCEPT; INTERLEUKIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; PSORIASIN; TUMOR NECROSIS FACTOR ALPHA; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; CYTOKINE; IMMUNOGLOBULIN RECEPTOR; PROTEIN S 100; S100A7 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL INFILTRATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; GENE LOCUS; GENETIC LINKAGE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INNATE IMMUNITY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSORIASIS; SIGNAL TRANSDUCTION; SKIN ABRASION; SKIN INFLAMMATION; TH17 CELL; ANIMAL; CELL CULTURE; CYTOLOGY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; SKIN; TRANSGENIC MOUSE;

ANIMALS; CELLS, CULTURED; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; KERATINOCYTES; MICE; MICE, TRANSGENIC; PSORIASIS; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650183999     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3001108     Document Type: Article

References (60)

1. A. B. Gottlieb, J. D. Bos, Recombinantly engineered human proteins: Transforming the treatment of psoriasis. Clin. Immunol. 105, 105-116 (2002).
2. C. E. Griffiths, J. N. Barker, Pathogenesis and clinical features of psoriasis. Lancet 370, 263-271 (2007).
3. B. J. Nickoloff, Keratinocytes regain momentum as instigators of cutaneous inflammation. Trends Mol. Med. 12, 102-106 (2006).
4. M. A. Lowes, A. M. Bowcock, J. G. Krueger, Pathogenesis and therapy of psoriasis. Nature 445, 866-873 (2007).
5. J. E. Gudjonsson, A. Johnston, H. Sigmundsdottir, H. Valdimarsson, Immunopathogenic mechanisms in psoriasis. Clin. Exp. Immunol. 135, 1-8 (2004).
6. D. J. Eedy, D. Burrows, J. M. Bridges, F. G. Jones, Clearance of severe psoriasis after allogenic bone marrow transplantation. BMJ 300, 908 (1990).
7. T. Wrone-Smith, B. J. Nickoloff, Dermal injection of immunocytes induces psoriasis. J. Clin. Invest. 98, 1878-1887 (1996).
8. A. Gilhar, M. David, Y. Ullmann, T. Berkutski, R. S. Kalish, T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice. J. Invest. Dermatol. 109, 283-288 (1997).
9. F. O. Nestle, C. Conrad, A. Tun-Kyi, B. Homey, M. Gombert, O. Boyman, G. Burg, Y. J. Liu, M. Gilliet, Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. J. Exp. Med. 202, 135-143 (2005).
10. A. M. Bowcock, J. G. Krueger, Getting under the skin: The immunogenetics of psoriasis. Nat. Rev. Immunol. 5, 699-711 (2005).
11. Y. Liu, C. Helms, W. Liao, L. C. Zaba, S. Duan, J. Gardner, C. Wise, A. Miner, M. J. Malloy, C. R. Pullinger, J. P. Kane, S. Saccone, J. Worthington, I. Bruce, P. Y. Kwok, A. Menter, J. Krueger, A. Barton, N. L. Saccone, A. M. Bowcock, A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 4, e1000041 (2008).
12. X. J. Zhang, W. Huang, S. Yang, L. D. Sun, F. Y. Zhang, Q. X. Zhu, F. R. Zhang, C. Zhang, W. H. Du, X. M. Pu, H. Li, F. L. Xiao, Z. X. Wang, Y. Cui, F. Hao, J. Zheng, X. Q. Yang, H. Cheng, C. D. He, X. M. Liu, L. M. Xu, H. F. Zheng, S. M. Zhang, J. Z. Zhang, H. Y. Wang, Y. L. Cheng, B. H. Ji, Q. Y. Fang, Y. Z. Li, F. S. Zhou, J. W. Han, C. Quan, B. Chen, J. L. Liu, D. Lin, L. Fan, A. P. Zhang, S. X. Liu, C. J. Yang, P. G. Wang, W. M. Zhou, G. S. Lin, W. D. Wu, X. Fan, M. Gao, B. Q. Yang, W. S. Lu, Z. Zhang, K. J. Zhu, S. K. Shen, M. Li, X. Y. Zhang, T. T. Cao, W. Ren, X. Zhang, J. He, X. F. Tang, S. Lu, J. Q. Yang, L. Zhang, D. N. Wang, F. Yuan, X. Y. Yin, H. J. Huang, H. F. Wang, X. Y. Lin, J. J. Liu, Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat. Genet. 41, 205-210 (2009).
13. D. Matthews, L. Fry, A. Powles, J. Weber, M. McCarthy, E. Fisher, K. Davies, R. Williamson, Evidence that a locus for familial psoriasis maps to chromosome 4q. Nat. Genet. 14, 231-233 (1996).
14. R. C. Trembath, R. L. Clough, J. L. Rosbotham, A. B. Jones, R. D. Camp, A. Frodsham, J. Browne, R. Barber, J. Terwilliger, G. M. Lathrop, J. N. Barker, Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum. Mol. Genet. 6, 813-820 (1997).
15. R. P. Nair, K. C. Duffin, C. Helms, J. Ding, P. E. Stuart, D. Goldgar, J. E. Gudjonsson, Y. Li, T. Tejasvi, B. J. Feng, A. Ruether, S. Schreiber, M. Weichenthal, D. Gladman, P. Rahman, S. J. Schrodi, S. Prahalad, S. L. Guthery, J. Fischer, W. Liao, P. Y. Kwok, A. Menter, G. M. Lathrop, C. A. Wise, A. B. Begovich, J. J. Voorhees, J. T. Elder, G. G. Krueger, A. M. Bowcock, G. R. Abecasis, Collaborative Association Study of Psoriasis, Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways. Nat. Genet. 41, 199-204 (2009).
16. J. T. Elder, A. T. Bruce, J. E. Gudjonsson, A. Johnston, P. E. Stuart, T. Tejasvi, J. J. Voorhees, G. R. Abecasis, R. P. Nair, Molecular dissection of psoriasis: Integrating genetics and biology. J. Invest. Dermatol. 130, 1213-1226 (2010).
17. R. de Cid, E. Riveira-Munoz, P. L. Zeeuwen, J. Robarge, W. Liao, E. N. Dannhauser, E. Giardina, P. E. Stuart, R. Nair, C. Helms, G. Escaramís, E. Ballana, G. Martín-Ezquerra, M. den Heijer, M. Kamsteeg, I. Joosten, E. E. Eichler, C. Lázaro, R. M. Pujol, L. Armengol, G. Abecasis, J. T. Elder, G. Novelli, J. A. Armour, P. Y. Kwok, A. Bowcock, J. Schalkwijk, X. Estivill, Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat. Genet. 41, 211-215 (2009).
18. S. Semprini, F. Capon, A. Tacconelli, E. Giardina, A. Orecchia, R. Mingarelli, T. Gobello, G. Zambruno, A. Botta, G. Fabrizi, G. Novelli, Evidence for differential S100 gene over-expression in psoriatic patients from genetically heterogeneous pedigrees. Hum. Genet. 111, 310-313 (2002).
19. M. P. Schön, Animal models of psoriasis-what can we learn from them? J. Invest. Dermatol. 112, 405-410 (1999).
20. A. G. Li, D. Wang, X. H. Feng, X. J. Wang, Latent TGFβ1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J. 23, 1770-1781 (2004).
21. Y. P. Xia, B. Li, D. Hylton, M. Detmar, G. D. Yancopoulos, J. S. Rudge, Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102, 161-168 (2003).
22. R. Zenz, R. Eferl, L. Kenner, L. Florin, L. Hummerich, D. Mehic, H. Scheuch, P. Angel, E. Tschachler, E. F. Wagner, Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437, 369-375 (2005).
23. S. Sano, K. S. Chan, S. Carbajal, J. Clifford, M. Peavey, K. Kiguchi, S. Itami, B. J. Nickoloff, J. DiGiovanni, Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. Med. 11, 43-49 (2005).
24. R. Donato, Intracellular and extracellular roles of S100 proteins. Microsc. Res. Tech. 60, 540-551 (2003).
25. R. L. Eckert, A. M. Broome, M. Ruse, N. Robinson, D. Ryan, K. Lee, S100 proteins in the epidermis. J. Invest. Dermatol. 123, 23-33 (2004).
26. P. Madsen, H. H. Rasmussen, H. Leffers, B. Honoré, K. Dejgaard, E. Olsen, J. Kiil, E. Walbum, A. H. Andersen, B. Basse, J. B. Lauridsen, G. P. Ratz, A. Celis, J. Vandekerckhove, J. E. Celis, Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J. Invest. Dermatol. 97, 701-712 (1991).
27. R. Wolf, A. Mirmohammadsadegh, M. Walz, B. Lysa, U. Tartler, R. Remus, U. Hengge, G. Michel, T. Ruzicka, Molecular cloning and characterization of alternatively spliced mRNA isoforms from psoriatic skin encoding a novel member of the S100 family. FASEB J. 17, 1969-1971 (2003).
28. R. Wolf, O. M. Howard, H. F. Dong, C. Voscopoulos, K. Boeshans, J. Winston, R. Divi, M. Gunsior, P. Goldsmith, B. Ahvazi, T. Chavakis, J. J. Oppenheim, S. H. Yuspa, Chemotactic activity of S100A7 (psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15. J. Immunol. 181, 1499-1506 (2008).
29. R. Wolf, C. J. Voscopoulos, P. C. FitzGerald, P. Goldsmith, C. Cataisson, M. Gunsior, M. Walz, T. Ruzicka, S. H. Yuspa, The mouse S100A15 ortholog parallels genomic organization, structure, gene expression, and protein-processing pattern of the human S100A7/A15 subfamily during epidermal maturation. J. Invest. Dermatol. 126, 1600-1608 (2006).
30. R. Wolf, T. Ruzicka, S. H. Yuspa, Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: Highly homologous but distinct in regulation and function. Amino Acids 10.1007/s00726-010-0666-4 (2010).
31. B. J. Nickoloff, R. S. Mitra, J. Varani, V. M. Dixit, P. J. Polverini, Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am. J. Pathol. 144, 820-828 (1994).
32. M. L. Giustizieri, F. Mascia, A. Frezzolini, O. De Pità, L. M. Chinni, A. Giannetti, G. Girolomoni, S. Pastore, Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J. Allergy Clin. Immunol. 107, 871-877 (2001).
33. C. Cataisson, A. J. Pearson, M. Z. Tsien, F. Mascia, J. L. Gao, S. Pastore, S. H. Yuspa, CXCR2 ligands and G-CSF mediate PKCα-induced intraepidermal inflammation. J. Clin. Invest. 116, 2757-2766 (2006).
34. R. Wolf, C. Voscopoulos, J. Winston, A. Dharamsi, P. Goldsmith, M. Gunsior, B. K. Vonderhaar, M. Olson, P. H. Watson, S. H. Yuspa, Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancer. Cancer Lett. 277, 101-107 (2009).
35. I. Diamond, T. Owolabi, M. Marco, C. Lam, A. Glick, Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. J. Invest. Dermatol. 115, 788-794 (2000).
36. K. Uyemura, M. Yamamura, D. F. Fivenson, R. L. Modlin, B. J. Nickoloff, The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J. Invest. Dermatol. 101, 701-705 (1993).
37. J. R. Chan, W. Blumenschein, E. Murphy, C. Diveu, M. Wiekowski, S. Abbondanzo, L. Lucian, R. Geissler, S. Brodie, A. B. Kimball, D. M. Gorman, K. Smith, R. de Waal Malefyt, R. A. Kastelein, T. K. McClanahan, E. P. Bowman, IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med. 203, 2577-2587 (2006).
38. R. Ghadially, J. T. Reed, P. M. Elias, Stratum corneum structure and function correlates with phenotype in psoriasis. J. Invest. Dermatol. 107, 558-564 (1996).
39. R. A. Miller, The Koebner phenomenon. Int. J. Dermatol. 21, 192-197 (1982).
40. H17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648-651 (2007).
41. R. Sabat, S. Philipp, C. Höflich, S. Kreutzer, E. Wallace, K. Asadullah, H. D. Volk, W. Sterry, K. Wolk, Immunopathogenesis of psoriasis. Exp. Dermatol. 16, 779-798 (2007).
42. N. J. Wilson, K. Boniface, J. R. Chan, B. S. McKenzie, W. M. Blumenschein, J. D. Mattson, B. Basham, K. Smith, T. Chen, F. Morel, J. C. Lecron, R. A. Kastelein, D. J. Cua, T. K. McClanahan, E. P. Bowman, R. de Waal Malefyt, Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8, 950-957 (2007).
43. F. Fantuzzi, M. Del Giglio, P. Gisondi, G. Girolomoni, Targeting tumor necrosis factor α in psoriasis and psoriatic arthritis. Expert Opin. Ther. Targets 12, 1085-1096 (2008).
44. C. Gebhardt, A. Riehl, M. Durchdewald, J. Németh, G. Fürstenberger, K. Müller-Decker, A. Enk, B. Arnold, A. Bierhaus, P. P. Nawroth, J. Hess, P. Angel, RAGE signaling sustains inflammation and promotes tumor development. J. Exp. Med. 205, 275-285 (2008).
45. J. Bhalerao, A. M. Bowcock, The genetics of psoriasis: A complex disorder of the skin and immune system. Hum. Mol. Genet. 7, 1537-1545 (1998).
46. J. T. Elder, R. P. Nair, J. J. Voorhees, Epidemiology and the genetics of psoriasis. J. Invest. Dermatol. 102, 24S-27S (1994).
47. I. Marenholz, A. Volz, A. Ziegler, A. Davies, I. Ragoussis, B. P. Korge, D. Mischke, Genetic analysis of the epidermal differentiation complex (EDC) on human chromosome 1q21: Chromosomal orientation, new markers, and a 6-Mb YAC contig. Genomics 37, 295-302 (1996).
48. S. C. Liang, X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, L. A. Fouser, Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271-2279 (2006).
49. J. D. Bos, M. A. de Rie, M. B. Teunissen, G. Piskin, Psoriasis: Dysregulation of innate immunity. Br. J. Dermatol. 152, 1098-1107 (2005).
50. H. Valdimarsson, B. S. Baker, I. Jónsdóttir, A. Powles, L. Fry, Psoriasis: A T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol. Today 16, 145-149 (1995).
51. E. Christophers, The immunopathology of psoriasis. Int. Arch. Allergy Immunol. 110, 199-206 (1996).
52. K. E. Nograles, L. C. Zaba, E. Guttman-Yassky, J. Fuentes-Duculan, M. Suárez-Fariñas, I. Cardinale, A. Khatcherian, J. Gonzalez, K. C. Pierson, T. R. White, C. Pensabene, I. Coats, I. Novitskaya, M. A. Lowes, J. G. Krueger, Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 159, 1092-1102 (2008).
53. B. J. Nickoloff, T. Wrone-Smith, Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am. J. Pathol. 155, 145-158 (1999).
54. J. E. Gudjonsson, A. Johnston, M. Dyson, H. Valdimarsson, J. T. Elder, Mouse models of psoriasis. J. Invest. Dermatol. 127, 1292-1308 (2007).
55. P. A. Labosky, D. P. Barlow, B. L. Hogan, Mouse embryonic germ (EG) cell lines: Transmission through the germline and differences in the methylation imprint of insulin-like growth factor 2 receptor (Igf2r) gene compared with embryonic stem (ES) cell lines. Development 120, 3197-3204 (1994).
56. U. Lichti, J. Anders, S. H. Yuspa, Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nat. Protoc. 3, 799-810 (2008).
57. V. V. Orlova, E. Y. Choi, C. Xie, E. Chavakis, A. Bierhaus, E. Ihanus, C. M. Ballantyne, C. G. Gahmberg, M. E. Bianchi, P. P. Nawroth, T. Chavakis, A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J. 26, 1129-1139 (2007).
58. C. Cataisson, A. J. Pearson, S. Torgerson, S. A. Nedospasov, S. H. Yuspa, Protein kinase Cα-mediated chemotaxis of neutrophils requires NF-κB activity but is independent of TNFα signaling in mouse skin in vivo. J. Immunol. 174, 1686-1692 (2005).
59. E. Y. Choi, E. Chavakis, M. A. Czabanka, H. F. Langer, L. Fraemohs, M. Economopoulou, R. K. Kundu, A. Orlandi, Y. Y. Zheng, D. A. Prieto, C. M. Ballantyne, S. L. Constant, W. C. Aird, T. Papayannopoulou, C. G. Gahmberg, M. C. Udey, P. Vajkoczy, T. Quertermous, S. Dimmeler, C. Weber, T. Chavakis, Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 322, 1101-1104 (2008).
60. T. Chavakis, A. Bierhaus, N. Al-Fakhri, D. Schneider, S. Witte, T. Linn, M. Nagashima, J. Morser, B. Arnold, K. T. Preissner, P. P. Nawroth, The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment. J. Exp. Med. 198, 1507-1515 (2003).